MIRA INFORM REPORT

 

 

Report Date :

13.06.2008

 

IDENTIFICATION DETAILS

 

Name :

MALLARD PHARMACEUTICALS (PRIVATE) LTD

 

 

Registered Office :

Zia Lodge, Jinnah Town District, Jail Road, Multan

 

 

Country :

Pakistan

 

 

Date of Incorporation :

2005

 

 

Com. Reg. No.:

0049649

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

Manufacture and Marketing of Pharmaceutical Products for human and Animal, Biological Medicine

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

 

 

 

 

 

 

Business Name

 

MALLARD PHARMACEUTICALS (PRIVATE) LTD

 

 

Full Address       

 

Registered Address

Zia Lodge, Jinnah Town District, Jail Road, Multan, Pakistan

                       

Tel

92 (61) 4543672, 4542731 

Fax

92 (61) 4510512

Website

thames@brain.net.pk

 

 

Short Description Of Business

 

Nature of Business           

Manufacture & Marketing of Pharmaceutical Products for human & Animal, Biological Medicine

Year Established

2005

Registration #

0049649

 

 

Factory Location

 

23 - K.M., Lahore Road,

Multan, Pakistan

 

 

Auditors

 

Mahboob Sheikh & Company

(Chartered Accountants)

Near HBL Building, Near Auto Plaza, Dera Adda Chowk, L.M.Q. Road, Multan, Pakistan

 

 

Legal Status

 

Subject Company was established as a Private Limited Company in 2005

 

 

Authorized Capital

Rs. 10,000,000/-

Issued & Paid up Capital

Rs. 10,000,000/-

 

 

 

 

 

Details of Chief Executive/ Directors

 

Names

Nationality

Address

Occupation

Designation

Mr. Zaheer-Ud-Din Babar

 

 

Mr. Mohaio-Ud-Din Aurangzeb Alamgir

 

Mr. Jalal-Ud-Din Akbar

 

 

Mr. Shahabuddin

 

 

 

Mr. Jahanzaib Humayoun

Pakistani

 

 

 

Pakistani

 

 

 

Pakistani

 

 

 

Pakistani

 

 

 

Pakistani

Zia Lodge, Jinnah Town District, Jail Road, Multan

 

Zia Lodge, Jinnah Town District, Jail Road, Multan

 

Zia Lodge, Jinnah Town District, Jail Road, Multan

 

Zia Lodge, Jinnah Town District, Jail Road, Multan

 

Zia Lodge, Jinnah Town District, Jail Road, Multan

Business

 

 

 

Business

 

 

 

Business

 

 

 

Business

 

 

 

Business

Chief Executive

 

 

 

Director

 

 

 

Director

 

 

 

Director

 

 

 

Director

 

 

Shareholders                

 

Names

Mr. Zaheer-Ud-Din Babar

 

Mr. Mohaio-Ud-Din Aurangzeb Alamgir

 

Mr. Jalal-Ud-Din Akbar

 

Mr. Shahabuddin

 

Mr. Jahanzaib Humayoun

 

 

Associates                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

 

A.         Subsidiary

 

None                                             

           

B.         Associated Companies

 

(1) Thames Pharmaceuticals, Pakistan.

 

 

 

 

 

 

Products / Services

 

Manufacture & Marketing of Pharmaceutical Products for human & Animal, Biological Medicine

 

 

Number of Employees

           

65

 

 

Trade Suppliers (Foreign)

 

MURLI KRISHNA (PVT) LIMITED, INDIA.

ZHUHAI UNITED LABORATORIES CO., LTD, CHINA.

 

 

Annual Production Volume

 

The capacity and production of the company’s plant is indeterminable as it involves varying processes of manufacture.

 

 

Annual Sales Volume

Year

In Pak Rupees

2007 - 2008

Not ascertained as the subject  recently started its commercial production

 

 

 

 

 

 

Customers

 

Company are in the process of making distributors in all major cities of Pakistan

 

 

Bankers

 

(1) National Bank of Pakistan, Pakistan.

     (Mortgage obtained PKR 10,000,000/-)

(2) Faysal Bank Limited, Pakistan.

(3) Standard Chartered Bank, Pakistan.

 

 

Memberships

 

 

 

 

Foreign Exchange Rates

 

Currency

 

Unit

Pakistani Rupee

US Dollar

1

           Rs. 67.70

UK Pound

1

           Rs. 131.45

Euro

1

           Rs. 104.20

 

 

Comments

 

Subject Company was established in 2005 and is engaged in manufacture & marketing of Pharmaceutical Products for human & Animal, Biological Medicine. Overall reputation is normal. Trade relations are reported as fair. The Company can be considered for normal business dealings at usual trade terms & conditions.

 

 

 

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions